Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 4/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2603400 | 0.86 | LTA4H (0.51) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL4275916 | 0.84 | LTA4H (0.52) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL2758615 | 0.83 | LTA4H (0.49) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL11249712 | 0.83 | PTGS2 (0.48) | SMN1; SMN2L3MBTL1ALDH1A1LMNA | |
| SCHEMBL11249716 | 0.83 | PTGS2 (0.48) | SMN1; SMN2L3MBTL1ALDH1A1LMNA | |
| SCHEMBL3468511 | 0.83 | PLA2G4B (0.58) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL4209775 | 0.82 | PLA2G4B (0.60) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL3467363 | 0.82 | PLA2G4B (0.60) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 | |
| SCHEMBL7353070 | 0.82 | PDE3B (0.45) | LTA4HL3MBTL1PDE3BPDE3AP2RY12 | |
| SCHEMBL10915135 | 0.81 | LTA4H (0.52) | LTA4HHDAC6KDM4ECYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9644099-B2 | Violet laser excitable dyes and their method of use | Life Technologies Corporation (US) | 2017-05-09 | — | — | US | disclosed |
| US-8158801-B2 | Violet laser excitable dyes and their method of use | Life Technologies Corporation (US) | 2012-04-17 | — | — | US | disclosed |
| US-20070077549-A1 | VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE | INVITROGEN CORPORATION (US) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070077549-A1 | VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE | KLK3, ALDH1A2, SPR | LTA4H 806/4885HDAC6 1988/4885KDM4E 468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.